The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease
Abstract
OBJECTIVES: Although the clinical efficacy of infliximab as measured by closure of fistulas in Crohn's disease has been demonstrated, its influence on the inflammatory changes in the fistula tracks is less clear. The aim of the present study was to assess the behavior of perianal fistulas before and after infliximab treatment. METHODS: Magnetic resonance imaging (MRI) and clinical evaluation were performed in a total of 18 patients before and after treatment with infliximab. An MRI-based score of perianal Crohn's disease severity was developed using both criteria of local extension of fistulas (complexity, supralavetoric extension, relation to the sphincters and of active inflammation (T2 hyperintensity, presence of cavities/abscesses, and rectal wall involvement). RESULTS: The MRI score was reliable in assessing the fistula tracks, with a good interobserver concordance (p < 0.001). Fistula tracks with signs of active inflammation were found in all 18 patients at baseline and collections in seven. After short-term infliximab treatment, active tracks persisted in eight of 11 patients who had clinically responded to infliximab. After long-term (46 wk) infliximab therapy, MRI signs of active track inflammation had resolved in three of six patients. CONCLUSIONS: We have developed an MRI-based score of perianal Crohn's disease severity to assess the anatomical evolution of Crohn's fistulas. Our study demonstrates that despite closure of draining external orifices after infliximab therapy, fistula tracks persist with varying degrees of residual inflammation, which may cause recurrent fistulas and pelvic abscesses. Whether complete fistula fibrosis occurs over time with repeated infliximab infusions needs further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Self-citationInfliximab for the Treatment of Fistulas in Patients with Crohn's Disease
Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., van Hogezand, R. A., Podolsky, D. K., Sands, B. E., Braakman, T., DeWoody, K. L., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401804 · Cited by 2,752
A classification of fistula-in-ano
Parks, A. G., Gordon, P. H., & Hardcastle, J. D. (1976) · Journal of British Surgery · doi:10.1002/bjs.1800630102 · Cited by 1,663
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
Rutgeerts, P., D'Haens, G., Targan, S., Vasiliauskas, E., Hanauer, S. B., Present, D. H., Mayer, L., Van Hogezand, R. A., Braakman, T., DeWoody, K. L., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70332-x · Cited by 1,080
Schwartz, D. A., Wiersema, M. J., Dudiak, K. M., Fletcher, J. G., Clain, J. E., Tremaine, W. J., Zinsmeister, A. R., Norton, I. D., Boardman, L. A., Devine, R. M., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.28676 · Cited by 575
Preoperative MR Imaging of Anal Fistulas: Does It Really Help the Surgeon?
Beets-Tan, R. G. H., Beets, G. L., van der Hoop, A. G., Kessels, A. G. H., Vliegen, R. F. A., Baeten, C. G. M. I., & van Engelshoven, J. M. A. (2001) · Radiology · doi:10.1148/radiology.218.1.r01dc0575 · Cited by 338
Ej, I. (1995) · PubMed · Cited by 305
Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging.
Haggett, P. J., Moore, N. R., Shearman, J. D., Travis, S. P., Jewell, D. P., & Mortensen, N. J. (1995) · Gut · doi:10.1136/gut.36.3.407 · Cited by 189
Diagnosis of fistulae and sinus tracts in patients with Crohn disease: value of MR imaging
Koelbel, G., Schmiedl, U., Majer, M., Weber, P., Jenss, H., Kueper, K., & Hess, C. (1989) · American Journal of Roentgenology · doi:10.2214/ajr.152.5.999 · Cited by 158
Cited by
Infliximab Maintenance Therapy for Fistulizing Crohn's Disease
Sands, B. E., Anderson, F. H., Bernstein, C. N., Chey, W. Y., Feagan, B. G., Fedorak, R. N., Kamm, M. A., Korzenik, J. R., Lashner, B. A., Onken, J. E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030815 · Cited by 2,226
Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Garcia-Olmo, D., Herreros, D., Pascual, I., Pascual, J. A., Del-Valle, E., Zorrilla, J., De-La-Quintana, P., Garcia-Arranz, M., & Pascual, M. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181973487 · Cited by 773
AGA technical review on perianal Crohn’s disease
Sandborn, W. J., Fazio, V. W., Feagan, B. G., & Hanauer, S. B. (2003) · Gastroenterology · doi:10.1016/j.gastro.2003.08.025 · Cited by 704
Panes, J., Bouhnik, Y., Reinisch, W., Stoker, J., Taylor, S. A., Baumgart, D. C., Danese, S., Halligan, S., Marincek, B., Matos, C., et al. (2013) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2013.02.020 · Cited by 668
Self-citation
Metadata
- Authors
- Van Assche, G.
- Venue
- The American Journal of Gastroenterology
- Published
- 2003-02
- Volume
- 98
- Issue
- 2
- Pages
- 332-339
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2105423417
- Cited by
- 457
- References
- 11
- FWCI
- 8.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. https://app.cochat.ai/papers/10.1016/s0002-9270(02)05909-9
- The paper
- Van Assche, G. (2003). Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. The American Journal of Gastroenterology. https://doi.org/10.1016/s0002-9270(02)05909-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.